We recognise the relationship between climate and health. Climate change will put the health ecosystem under pressure across all stakeholders – health providers, patient and payers – in low-, middle- and high-income settings. Therefore, we take actions to reduce our carbon emissions and adapt to the shifts in health systems across our value chain and in our product portfolio.

In the scientific debate, we refer to the findings of the UN Intergovernmental Panel on Climate Change (IPCC). 

Since 2020, all our production sites have sourced renewable power, and we have a target of reaching zero CO₂ emissions from own operations (Scope 1 and 2) by 2030. We target to reduce scope 3 emissions with 33% by 2033 compared to 2024 and have net zero emissions by 2045.

Read more about our CO₂ targets and actions here

We adhere to the principles of the Greenhouse Gas Protocol (GHG protocol) when reporting and setting targets on carbon emissions.  

We recognise the need to broaden the scope of climate action to the supply chain and work with key suppliers to limit the carbon emission as the main priority under Scope 3. We share experience and learnings to support suppliers in finding the best carbon reducing measures, including energy efficiency and production or sourcing of renewable energy. Furthermore, we implement low carbon materials and services in collaboration with suppliers.

We reduce our CO₂ emissions by increasing the efficiency of our activities and implementing energy efficiency programmes. Secondly, we base our consumption on renewable energy, where we cooperate with energy suppliers. When we source renewable energy, we give priority to bringing additional renewable energy into the market.

Renewable energy can be based on wind, solar, hydro or biomass. When sourcing energy based on biomass, we ensure that the biomass comes from sustainable sources. Biomass, such as wood chips used for steam and heat production, must be based on sustainable sources certified by competent bodies. Biogas is based on our own yeast slurry and waste from farming and food industry.

Recognising the complexity and cross cutting nature of climate change, Novo Nordisk has taken a partnership approach to address this global challenge. We encourage partnerships and believe that this approach often leads to better and more innovative solutions.

Novo Nordisk is a member of RE100 and EV100 and committed to achieving net zero emissions by 2045 in line with the requirements established by Science Based Targets initiative. Novo Nordisk is also a part of the World Economic Forum’s Alliance of CEO Climate Leaders and the Sustainable Markets Initiative health system task force to deliver net zero healthcare.